Sanara MedTech (SMTI) announced the appointments of Jake Waldrop as COO and Tyler Palmer as Chief Corporate Development and Strategy Officer. Most recently Mr. Waldrop held the position of CFO for Trilliant Surgical, and after their sale to Enovis in early 2021, Jake held the position of Vice President of Finance and Integrations for the newly founded Foot and Ankle division of Enovis (ENOV). On his most recent role, Mr. Palmer served as the Senior Vice President of Corporate Development, Strategy, and Product at AQuity Solutions. Mr. Waldrop’s appointment is effective April 15, 2024 and Mr. Palmer’s appointment was effective April 1, 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMTI:
- Sanara MedTech price target lowered to $44 from $49 at Cantor Fitzgerald
- Sanara MedTech’s Balancing Act: Navigating High Debt and Competitive Pressures in a Rising Rate Landscape
- SMTI Upcoming Earnings Report: What to Expect?
- Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
- Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
